The ACR Board of Directors (http://www.rheumatology.org/about/leadership/bod.asp) met Thursday, Feb. 20–Saturday, Feb. 22, 2014, in Napa, Calif. The following is a list of actions approved at the meeting. A more detailed summary of their actions and discussions can be found at http://www.rheumatology.org.
Nominations: Two hundred and thirty-three new and returning ACR/ARHP candidates were approved for membership. Additionally, in October 2013, the ACR board of directors approved expanding the size of the RheumPAC committee, and in February the board approved Dannette Johnson, DO, and Vicki Merrell, PA-C, as its newest volunteers.
Quality of Care: An ACR partnership with EULAR to support new lupus classification criteria was approved as part of the committees’ work plan for the next fiscal year.
Government Affairs: The board of directors approved a comprehensive update of the ACR Policy Statements for 2014, developed to guide ACR advocacy activities by providing an overview of issues impacting the rheumatology community.
Rheumatologic Care: The board approved new and modified position statements. ACR position statements represent the ACR’s stance on issues that affect the rheumatology community and/or the patients rheumatologists treat.
- Beer’s List position statement—new
- Musculoskeletal Ultrasound position statement—new
- Synovial Fluid Crystal Analysis position statement—updated
- Viscosupplementation position statement—new
The ACR board of directors will meet again in Washington, D.C., May 15–16, 2014, in conjunction with a lobbying effort on Capitol Hill.
